Observations on the mechanism of action of FK-506: A pharmacologic probe of lymphocyte signal transduction
- 15 November 1990
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (10) , 2201-2208
- https://doi.org/10.1016/0006-2952(90)90712-t
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- T-Lymphocyte-Antigen Interactions in Transplant RejectionNew England Journal of Medicine, 1990
- The mechanism of action of the immunosuppressive drug FK-506Cellular Immunology, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- FK-506 — How much potential?Immunology Today, 1989
- Inhibition of Histamine and Prostaglandin D2 Release from Human Lung Mast Cells by Ciclosporin AInternational Archives of Allergy and Immunology, 1989
- Immunosuppressive effect of FK506 on collagen-induced arthritis in ratsClinical Immunology and Immunopathology, 1988
- PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506Transplantation, 1988
- Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in ratsInternational Journal of Immunopharmacology, 1988
- PROTEIN KINASE ACTIVATION AND THE IMMUNOSUPPESSANT CYCLOSPORINETransplantation, 1986